🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

229 results for “Ovid” Clear

  1. TD-0903

    Theravance Biopharma Ireland Umited

    Acute Lung Injury (ALI) Associated With COVID-19

    phase 2 small molecule completed

    2 trials

  2. TEV-48574, Placebo IMP for sc infusion is provided as a liquid solution in the same formulation as TEV-48574, except for the absence of active protein.

    Lacuna Pharma Pty Ltd

    Crohn’s disease, Ulcerative colitis

    phase 2 small molecule active

    1 trial

  3. Tafenoquine Oral Tablet

    60 DEGREES PHARMACEUTICALS, INC.

    COVID 19 Disease

    phase 2 small molecule completed

    1 trial

  4. Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    1 trial

  5. Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    2 trials

  6. UB-612

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 mab completed

    4 trials

  7. Ursodeoxycholic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 small molecule completed

    1 trial

  8. Veklury 100 mg powder for concentrate for solution for infusion

    MEDA Pharma GmbH & Co. KG

    COVID-10 infection

    phase 2 small molecule active

    1 trial

  9. Voclosporin

    Aurinia Pharmaceuticals

    Covid19

    phase 2 small molecule completed

    1 trial

  10. Vortioxetine

    COGNITION THERAPEUTICS INC

    Post-COVID-19 Condition

    phase 2 small molecule completed

    1 trial

  11. accelerated intermittent theta burst stimulation

    United Therapeutics Europe Ltd

    Long COVID

    phase 2 other active

    1 trial

  12. casirivimab+imdevimab

    Regeneron UK Limited

    COVID-19

    phase 2 small molecule terminated

    2 trials

  13. lanadelumab

    Takeda

    COVID-19

    phase 2 mab completed

    1 trial

  14. low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 2 mab completed

    1 trial

  15. placebo

    The First People's Hospital of Lianyungang

    COVID-19 Thalidomide

    phase 2 small molecule active

    1 trial

  16. A clinical study of MK-1289 in healthy adult men (MK-1289-001)

    Merck Sharp and Dohme

    COVID-19 Infection

    phase 1 other active

    1 trial

  17. ALG-097558

    Aligos Therapeutics

    COVID-19

    phase 1 small molecule completed

    3 trials

  18. APR002

    BRIGHT MINDS BIOSCIENCES INC.

    COVID-19

    phase 1 small molecule completed

    1 trial

  19. BGB DXP593

    BeiGene

    Covid19

    phase 1 small molecule completed

    1 trial

  20. Bempegaldesleukin

    Nektar Therapeutics UK Limited

    Covid-19

    phase 1 small molecule completed

    1 trial

  21. CLBS119

    LISATA THERAPEUTICS, INC.

    Covid-19

    phase 1 mab terminated

    1 trial

  22. COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use

    Lxo Ireland Designated Activity Company

    Covid19

    phase 1 mab active

    1 trial

  23. COVID-HIG

    United Therapeutics Europe Ltd

    SARS-CoV-2 Infection

    phase 1 mab completed

    1 trial

  24. COVID-HIGIV

    United Therapeutics Europe Ltd

    COVID-19

    phase 1 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources